Monday, February 08, 2021 4:36:27 PM
1. Covi-Stix rapid accurate virus test
2. Covi-Track rapid accurate antibody test
3. Covi-push 2020 injection
4. Covi-Drops 2020 nose drops
5. Covi-Vax 2020 lipid DNA injection
6. Abivirtinib ARDS prevention
7. Covi-MSC Stem Cell ARDS treatment
8. Covi-Shield antibody cocktail
Each of these EUA's could be accompanied by Operation Warp Speed grants and multi-billion dollar international sales. Additionally there could multi-billion dollar worldwide marketing partnerships. Dr.Ji says there is "humungous" interest from Mexico, Brazil and Europe.
Timing? Some could come in days. Some in weeks. Others in several months.
In addition to these 8 Covid EUA candidates Sorrento has other potential multi $Billion programs ... here are 2 samples from each of the three portfolio areas...with at least 4 with 2021 revenue potential!
NON-OPIOID PAIN
1. SP-102 phase 3 over 90% enrolled, fast track, lumbar/sciatic pain
2. RTX intractable cancer, knee and arthritic pain
COVID
1. rapid, accurate, low cost tests. TRACK, TRACE, STIX
2. 2020 DROPS, injection and plasmid DNA
CANCER
1. Abivirtinib NSCLC phase 3, lymphomas phase 2, prostate IND, lupus
2. SmartPharm plasmid DNA Plus DAR-T and Mayo Clinic ADNIC drugs.
In summary in 2021 I look forward to the advance and/or approval of all 3 Covid tests; all 3 delivery forms of 2020; all 3 uses of Abivirtinib; all 3 applications of RTX; and all 3 non-opioid pain treatments. In 2021 we will start to see the payoff of the SmartPharm , ACEA and Mayo Clinic technology acquisitions. And 2021 will see half a dozen EUA's, settlement of the PSS lawsuit, maturation of the Celularity and ImmunityBio investments, and several large government grants and the beginning of large scale cash flow.
Everyone should read carefully the Transcript of the January 20, 2021 Riley Oncology Conference. It is loaded with important information for investors.
https://seekingalpha.com/article/4400090-sorrento-therapeutics-inc-srne-ceo-henry-ji-presents-b-riley-virtual-oncology-conference?utm_source=dowjonesnewswire.com&utm_medium=referral
And have a look at the January 2021 corporate presentation.
https://investors.sorrentotherapeutics.com/static-files/c7e5a3a2-7849-42e7-b531-2e6a7a7f3e94
"The refusal of the real is the number one dogma of our time" Rene Girard
Recent SRNE News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM